Recursion Pharmaceuticals
RXRX
#4168
Rank
HK$16.09 B
Marketcap
HK$40.04
Share price
0.98%
Change (1 day)
-45.39%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - Cash on Hand

Cash on Hand as of December 2024 : HK$4.62 Billion

According to Recursion Pharmaceuticals's latest financial reports the company has HK$4.62 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Recursion Pharmaceuticals - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$4.61 B50.88%
2023-12-31HK$3.05 B-28.82%
2022-12-31HK$4.29 B6.67%
2021-12-31HK$4.02 B98.22%
2020-12-31HK$2.03 B273.36%
2019-12-31HK$0.54 B